SHREWSBURY STEPHEN B
Insider CIK 1413821 · AQXP CMO; Senior VP Clinical Dev. · IMPL Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMPL IMPEL NEUROPHARMA INC | M Exercise deriv | 2022-03-29 | 2022-03-30 | 24,606 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | M Exercise | 2022-03-29 | 2022-03-30 | 24,606 | $1.97 | $48.5K | 97,990 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | A Award deriv | 2022-01-26 | 2022-01-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | M Exercise deriv | 2021-09-21 | 2021-09-22 | 14,780 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | M Exercise deriv | 2021-09-21 | 2021-09-22 | 4,650 | — | $0 | 541 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | M Exercise deriv | 2021-09-21 | 2021-09-22 | 53,954 | — | $0 | 29,587 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | M Exercise | 2021-09-21 | 2021-09-22 | 14,780 | $1.97 | $29.1K | 14,780 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | M Exercise | 2021-09-21 | 2021-09-22 | 4,650 | $2.46 | $11.4K | 19,430 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | M Exercise | 2021-09-21 | 2021-09-22 | 53,954 | $2.95 | $159.2K | 73,384 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | A Award deriv | 2021-07-20 | 2021-07-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2016-03-10 | 2016-03-14 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2015-03-12 | 2015-03-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2014-05-08 | 2014-05-12 | 31,250 | — | $0 | 31,250 | SEC↗ |